Improved Retinal Ganglion Cell Survival through Retinal Microglia Suppression by a Chinese Herb Extract, Triptolide, in the DBA/2J Mouse Model of Glaucoma

References

• Quigley HA, Broman At. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–267
   PubMed Web of Science ®Google Scholar
• Tezel G. Immune regulation toward immunomodulation for neuroprotection in glaucoma. Curr Opin Pharmacol. 2013;13:23–31
   PubMed Web of Science ®Google Scholar
• Tezel G, Wax MB. The immune system and glaucoma. Curr Opin Ophthalmol. 2004;15:80–84
   PubMedGoogle Scholar
• O'Hare F, Rance G, McKendrick AM, Crowston JG. Is primary open-angle glaucoma part of a generalized sensory neurodegeneration? A review of the evidence. Clin Exp Ophthalmol. 2012;40:895–905
   PubMedGoogle Scholar
• Danesh-Meyer HV. Neuroprotection in glaucoma: recent and future directions. Curr Opin Ophthalmol. 2011;22:78–86
   PubMed Web of Science ®Google Scholar
• Johnson TV, Martin KR. Cell transplantation approaches to retinal ganglion cell neuroprotection in glaucoma. Curr Opin Pharmacol. 2013;13:78–82
   PubMedGoogle Scholar
• Glezer I, Simard AR, Rivest S. Neuroprotective role of the innate immune system by microglia. Neuroscience. 2007;147:867–883
   PubMedGoogle Scholar
• Cunningham C. Microglia and neurodegeneration: the role of systemic inflammation. Glia. 2013;61:71–90
   PubMed Web of Science ®Google Scholar
• Graeber, Manuel B. Changing face of microglia. Science. 2010;330:783–788
   PubMed Web of Science ®Google Scholar
• Kim SU, de Vellis J. Microglia in health and disease. J Neurosci Res. 2005;81:302–313
   PubMed Web of Science ®Google Scholar
• Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8:57–69
   PubMed Web of Science ®Google Scholar
• Naert G, Rivest S. The role of microglial cell subsets in Alzheimer's disease. Curr Alzheimer Res. 2011;8:151–155
   PubMedGoogle Scholar
• Tichauer JE, von Bernhardi R. Transforming growth factor-β stimulates β amyloid uptake by microglia through Smad3-dependent mechanisms. J Neurosci Res. 2012;90:1970–1980
   PubMed Web of Science ®Google Scholar
• Wang XJ, Yan ZQ, Lu GQ, et al. Parkinson disease IgG and C5a-induced synergistic dopaminergic neurotoxicity: role of microglia. Neurochem Int. 2007;50:39–50
   PubMed Web of Science ®Google Scholar
• Rasmussen S, Imitola J, Ayuso-Sacido A, et al. Reversible neural stem cell niche dysfunction in a model of multiple sclerosis. Ann Neurol. 2011;69:878–891
   PubMed Web of Science ®Google Scholar
• Bosco A, Steele MR, Vetter ML. Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol. 2011;519:599–620
   PubMedGoogle Scholar
• Taylor S, Calder CJ, Albon J, et al. Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma. Exp Eye Res. 2011;92:338–343
   PubMedGoogle Scholar
• Ebneter A, Casson RJ, Wood JP, et al. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci. 2010;51:6448–6460
   PubMedGoogle Scholar
• Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res. 2001;64:523–532
   PubMed Web of Science ®Google Scholar
• Tezel G, Li LY, Patil RV, et al. Tumor necrosis factor-alpha and its receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2001;42:1787–1794
   PubMed Web of Science ®Google Scholar
• Tezel G, Wax MB. Glial modulation of retinal ganglion cell death in glaucoma. J Glaucoma. 2003;12:63–68
   PubMed Web of Science ®Google Scholar
• Bosco A, Inmma DM, Steele MR, et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1437–1446
   PubMed Web of Science ®Google Scholar
• Han R, Rostami-Yazdi M, Gerdes S, et al. Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases. Br J Clin Pharmacol. 2012;74:424–436
   PubMed Web of Science ®Google Scholar
• Wang Y, Mei Y, Feng D, et al. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurosci Res. 2008;86:2441–2449
   PubMedGoogle Scholar
• Liu J, Shen M, Yue Z, et al. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21. Phytomedicine. 2012;19:756–762
   PubMed Web of Science ®Google Scholar
• Qiu DM, Kao PN. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook F. Drugs RD. 2003;4:1–18
   PubMedGoogle Scholar
• Chen BJ. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk Lymphoma. 2001;42:253–265
   PubMed Web of Science ®Google Scholar
• Matta R, Wang X, Ge H, et al. Triptolide induces anti-inflammatory cellular responses. Am J Transl Res. 2009;1:267–282
   PubMed Web of Science ®Google Scholar
• Brinker AM, Ma J, Lipsky PE, et al. Medicinal chemistry and pharmacology of genus Triptergium (Celastraceae). Phytochemistry. 2007;68:732–766
   PubMed Web of Science ®Google Scholar
• Zhou HF, Niu DB, Xue B, et al. Triptolide inhibits TNF-α, IL-1β and NO production in primary microglial cultures. Neuroreport. 2003;14:1091–1095
   PubMedGoogle Scholar
• Zhou HF, Liu XY, Niu DB, et al. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Neurobiol Dis. 2005;18:441–449
   PubMedGoogle Scholar
• Li FQ, Lu XZ, Liang XB. Triptolide, a Chinese herbal extract, protects dopaminergic neurons from inflammation-mediated damage through inhibition of microglial activation. J Neuroimmunol. 2004;148:24–31
   PubMed Web of Science ®Google Scholar
• Jiao J, Xue B, Zhang L, et al. Triptolide inhibits amyloid-beta1-42-induced TNF-alpha and IL-1beta production in cultured rat microglia. J Neuroimmunol. 2008;205:32–36
   PubMed Web of Science ®Google Scholar
• John SW, Smith RS, Savinova OV, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39:951–962
   PubMed Web of Science ®Google Scholar
• Libby RT, Anderson MG, Pang I-H, et al. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci. 2005;22:1–12
   PubMedGoogle Scholar
• Yang L, Guo X, Wu L, et al. Retinal ganglion cell death in a DBA/2J mouse model of glaucoma-microglia activation and intraocular pressure. Neural Regen Res. 2010;5:273–281
   Google Scholar
• Chen M, Lv Z, Jiang S. The effects of triptolide on airway remodelling and transforming growth factor—β1/Smad signalling pathway in ovalbumin-sensitized mice. Immunology. 2011;132:376–384
   PubMedGoogle Scholar
• Gao Q, Shen W, Qin W, et al. Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Nephrol Dial Transplant. 2010; 25:3539–3547
   PubMed Web of Science ®Google Scholar
• Leuenroth SJ, Bencivenga N, Chahboune H, et al. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD. Nephrol Dial Transplant. 2010;25:2187–2194
   PubMed Web of Science ®Google Scholar
• Antonoff MB, Chugh R, Borja-Cacho D, et al. Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo. Surgery. 2009;146:282–290
   PubMedGoogle Scholar
• John SW, Hagaman JR, MacTaggart TE, et al. Intraocular pressure in inbred mouse strains. Invest Ophthalmol Vis Sci. 1997; 38:249–253
   PubMedGoogle Scholar
• Drager UC, Olsen JF. Ganglion cell distribution in the retina of the mouse. Invest Ophthalmol Vis Sci. 1981;20:285–293
   PubMed Web of Science ®Google Scholar
• Majed HH, Chandran S, Niclou SP, et al. A novel role for Sema3A in neuroprotection from injury mediated by activated microglia. J Neurosci. 2006;26:1730–1738
   PubMedGoogle Scholar
• Inman DM, Horner PJ. Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. Glia. 2007;55:942–953
   PubMedGoogle Scholar
• Chen X, Murakami T, Oppenheim JJ, et al. Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking. Blood. 2005;106:2409–2416
   PubMed Web of Science ®Google Scholar
• Schuettauf F, Rejdak R, Walski M, et al. Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol. 2004;107:352–358
   PubMed Web of Science ®Google Scholar
• Ebneter A, Casson RJ, Wood JP, et al. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci. 2010;51:6448–6460
   PubMedGoogle Scholar
• Naskar R, Wissing M, Thanos S. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. Invest Ophthalmol Vis Sci. 2002;43:2962–2968
   PubMed Web of Science ®Google Scholar
• Johnson, EC., Morrison, JC. Friend or Foe? Resolving the impact of glial responses in glaucoma. J Glaucoma. 2009;18:341–353
   PubMedGoogle Scholar
• Bosco A, Steele MR, Vetter ML. Early Microglia activation in a mouse model of chronic glaucoma. J Comp Neurol. 2011;519:599–620
   PubMedGoogle Scholar
• Ju WK, Kim KY, Duong-Polk KX, et al. Increased optic atrophy type 1 expression protects retinal ganglion cells in a mouse model of glaucoma. Mol Vis. 2010;16:1331–1342
   PubMedGoogle Scholar
• Fuchs C, Forster V, Balse E, et al. Retinal-cell-conditioned medium prevents TNF-α-induced apoptosis of purified ganglion cells. Invest Ophthalmol Vis Sci. 2005;46:2983–2991
   PubMed Web of Science ®Google Scholar
• Tezel G, Wax MB. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci. 2000;20:8693–8700
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Nakazawa C, Matsubara A, et al. Tumor necrosis factor-α mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci. 2006;26:12633–12641
   PubMed Web of Science ®Google Scholar
• Fontaine V, Mohand-Said S, Hanoteau N, et al. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci. 2002;22:RC216
   PubMed Web of Science ®Google Scholar
• Zhou XH, Li F, Kong L, et al. Involvement of inflammation, degradation and apoptosis in a mouse model of glaucoma. J Biol Chem. 2005;280:31240–31248
   PubMed Web of Science ®Google Scholar
• Saleh M, Nagaraju M, Porciatti V. Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2007;48:4564–4572
   PubMedGoogle Scholar
• Scholz M, Buder T, Seeber S, et al. Dependency of intraocular pressure elevation and glaucomatous changes in DBA/2J and DBA/2J-Rj mice. Invest Ophthalmol Vis Sci. 2008;49:613–621
   PubMed Web of Science ®Google Scholar